Precirix
PrivateLast Round
Series B
Mar 16, 2022
Total Funding Raised
$130.01M
Company Overview
Precirix operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was a Series B round in March 2022.
Precirix is a biotechnology company that develops targeted radiopharmaceuticals for cancer therapy using camelid single-domain antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precirix Comparables
Compare Precirix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TwoStep Therapeutics | 84% | |
| Ariceum Therapeutics | 84% | |
| Alpha-9 Oncology | 84% |
For institutional investors. Book with your work email.
Precirix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 16, 2022 | ||||
| Grant | Jan 1, 2019 | ||||
| Series A | Nov 15, 2018 | ||||
| Seed | Oct 14, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Precirix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B, Series A |
| Forbion | Series B |
| Gimv | Series B, Series A |
| Pontifax Venture Capital | Series B, Series A |
| HealthCap | Series B, Series A |
| V-Bio Ventures | Series B, Series A |
| Novo Holdings | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2022
$88M round led by Jeito, Inkef Capital, and Forbion.
- Jan 1, 2019
$8.4K grant received from Innoviris.
For institutional investors. Book with your work email.
Precirix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Precirix's valuation, stock price, and market status.
Is Precirix a public or private company?
Precirix is a private company.
What is the current stock price of Precirix?
Precirix is a private company, so its shares have no public market price. Caplight tracks Precirix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Precirix worth (valuation)?
Valuation information for Precirix is not publicly available.
Can I buy Precirix stock?
Precirix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Precirix's last funding round?
Precirix's most recent funding round was Series B on March 16, 2022.
Who are the main investors in Precirix?
Key investors in Precirix include Forbion, Gimv, V-Bio Ventures, Inkef Capital, Jeito Capital.
Will Precirix IPO soon?
No public IPO plans have been announced for Precirix.
How can I track Precirix secondary market activity?
Caplight tracks bids, offers, and trades in Precirix's shares on secondary markets.